Malignant Ovarian Brenner Tumor
NCI Definition: A malignant neoplasm that arises from the ovary and is characterized by the presence of an invasive malignant transitional cell component and nests of benign transitional cells in a fibrotic stroma. When the neoplasm is confined to the ovary, the prognosis is good. 
There is 1 clinical trial for malignant ovarian brenner tumor, of which 1 is open and 0 are completed or closed. Of the trial that contains malignant ovarian brenner tumor as an inclusion criterion, 1 is phase 1/phase 2 (1 open).
Carboplatin, defactinib, and paclitaxel are the most common interventions in malignant ovarian brenner tumor clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.